Healthcare -
Biotechnology - NASDAQ - US
$ 1.065
-4.05 %
$ 123 M
Market Cap
-11.83
P/E
CHRS - CASH & EQUIVALENTS
Cash & Equivalents CHRS - Coherus BioSciences, Inc.
103 M
LAST VALUE
-50.34%
2 YEAR CAGR
7.30%
5 YEAR CAGR
10.03%
10 YEAR CAGR